home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Navigating Early-Phase Clinical Trials: Key Considerations for Emerging Biotech and MedTech

 
  October 29, 2024  
     
 
Xtalks, Online
2024-12-03


Early-phase clinical trials, including First-in-Human (FIH) studies, represent pivotal milestones for emerging biotech and MedTech companies. Success during these initial stages not only sets the foundation for US Food and Drug Administration (FDA) approval but also ensures long-term commercial viability, including market access and payer reimbursement.

The path to achieving these objectives is often filled with challenges such as navigating complex regulatory requirements, designing trials that can accommodate future phases and implementing scalable clinical data management systems (CDMS)/electronic data capture systems (EDCS) to handle increasing volumes of data.

In this webinar, the expert speakers will guide the audience through key strategies for overcoming the most common hurdles encountered in early-phase clinical trials. They will provide insights into optimizing trial design for scalability, selecting technology solutions that support long-term growth and ensuring high standards of data quality across all phases.

The attendees will also gain an understanding of how a robust approach to data management not only helps meet regulatory requirements but also improves operational efficiency, accelerates timelines and strengthens the case for payer reimbursement. The discussion will cover practical aspects of early-phase trial management, including common pitfalls that can delay or derail progress and how to proactively address them.

The speakers will also share real-world examples of companies that have successfully navigated these early stages, including strategies they employed to achieve regulatory milestones and prepare for future trial phases. The panel will discuss how to choose the right CDMS/EDC features to support evolving needs and maintain data integrity, thus emphasizing the importance of adaptability in clinical research.

Register for this webinar today to accelerate the path to approval and ensure that early-phase trials set the stage for future growth and commercial success.

Keywords: Clinical Research, Electronic Data Capture, Regulatory, Data Management, Clinical Data Management, Clinical Trial Data Management, Commercialization/HEOR/Market Access
 
 
Organized by: Xtalks
Invited Speakers: Nicole Latimer, Chief Executive Officer, Medrio
Kate Smith, MPH, Vice President, Clinical Affairs, Lumicell
 
Deadline for Abstracts: 2024-12-03
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.